Abbott Gains Expanded Coverage For FreeStyle Libre 2 CGM In France
The reimbursement expansion for Abbott’s FreeStyle Libre 2 for basal insulin bodes well for continued basal coverage expansion into other geographies and commercial payers.
The reimbursement expansion for Abbott’s FreeStyle Libre 2 for basal insulin bodes well for continued basal coverage expansion into other geographies and commercial payers.